Darpan News Desk The Canadian Press, 05 Feb, 2024 04:35 PM
One person was left with burns on their hands after a vehicle fire in Vancouver's Downtown Eastside.
Officials say there was heavy fire coming from the vehicle when crews arrived just before 10 a-m at Powell Street and Gore Avenue.
Fire crews on scene at Powell and Gore for a vehicle fire. Powell Street between Dunlevy and Gore closed. 1 person with minor injuries. pic.twitter.com/XDjBq8TLlG
— Vancouver Fire Rescue Services (@VanFireRescue) February 5, 2024
The captain of Vancouver Fire Rescue Services says the person who was injured was taken to hospital for treatment.
While early indications showed the virus was spread by droplets that settled on surfaces, Silas, president of the Canadian Federation of Nurses, urged health authorities to learn from the SARS outbreak of 2003 and take the highest level of precaution.
Though the rate of people who are hospitalized with Omicron is lower compared to the Delta variant, the forecast shows new daily hospital admissions will far exceed previous historical peaks due to the sheer number of cases.
Everything from who gets tested to who's most likely to contract the virus has changed with the latest wave of the pandemic, and that's posing distinct challenges for those who model its impact, says Caroline Colijn, an associate professor of mathematics at Simon Fraser University in British Columbia.
The Tory leader made his position known on Premier François Legault's proposal during a Facebook Liveevent late Thursday. Some of his MPs had already taken to social media to condemn the proposal as discriminatory, unethical and punishing to low-income earners.
Sheila Malcolmson, the minister of mental health and addictions, says the program dubbed the Tailgate Toolkit was developed on Vancouver Island last year in partnership with people in the industry who have experience with illicit drug use.
Canadian health leaders and some premiers have been publicly pressuring Health Canada to greenlight the medication, which prevents the SARS-CoV-2 virus that causes COVID-19 from reproducing within a patient's body. Pfizer's clinical trial showed for high-risk patients it prevented hospitalizations by about 90 per cent.
